AIThis post was created with the assistance of artificial intelligence (AI).

TL;DR

Before you orderOffer from Amazon

Get everyday helpers delivered free with Prime

  • Fast, free delivery on millions of items
  • Prime Video, Amazon Music and more included
  • Member-only deals all year
Start your free Prime trial Free trial for eligible customers · Cancel anytime
As an affiliate, we earn on qualifying purchases.

Analysts say Democrats taking control of Congress next year may investigate HHS Secretary Robert F. Kennedy Jr. and revisit surprise billing, Medicaid cuts and health spending oversight. Those are possible priorities, not enacted plans; the experts cited expect limited legislative room without a veto-proof Senate majority.

With Democrats set to control Congress next year, health policy analysts say lawmakers may investigate Health and Human Services Secretary Robert F. Kennedy Jr. and consider changes to the No Surprises Act, Medicaid policy and federal health spending. The ideas are possible priorities, not commitments by congressional leaders, and experts say the Senate’s makeup will limit which proposals can pass.

Bruce Mirken, communications co-chair at Defend Public Health, said the new Congress should conduct a “complete and thorough investigation” of Kennedy’s record. He argued that an inquiry should examine what he described as malfeasance and disinformation, and said it could lead to articles of impeachment. Those are Mirken’s allegations and proposed response; the report does not describe an investigation already underway or a decision by lawmakers to pursue impeachment.

Mirken also called for Congress to review how the administration and HHS have handled money appropriated by lawmakers. He said oversight should examine effects on disease monitoring, food safety and health research. The report does not quantify those effects or provide an official response from HHS.

Other proposals include revisiting flaws in the No Surprises Act, which protects patients from many unexpected out-of-network medical bills, and pursuing measures to curb health costs. Thomas Campanella, a health economics professor emeritus and consultant, listed site-neutral hospital payments, stricter antitrust enforcement, oversight of the 340B drug pricing program, and clearer price and quality information as possible areas of focus. He also cited bipartisan support for greater investment in primary care and rural health care.

At a glance
reportWhen: Reported November 4, 2026; the new Cong…
The developmentAnalysts outlined possible health policy priorities for the Democratic-controlled Congress taking office next year, including scrutiny of RFK Jr. and changes to surprise billing rules.

Oversight and Patient Cost Proposals

The potential agenda spans both oversight of federal health agencies and policies that affect patients’ costs and access to care. Changes to the No Surprises Act could affect how disputes over certain out-of-network bills are handled, while Medicaid decisions could shape coverage and funding for hospitals and other providers. The source does not specify the exact revisions analysts expect lawmakers to pursue.

Investigations could also test Congress’s authority over agencies and spending. Mirken says lawmakers should examine HHS decisions and seek to reverse damage he attributes to the administration. Whether those claims lead to hearings, legislation or other formal action depends on choices by congressional leaders; none had been announced in the report.

The proposals also touch the balance between affordability and the financial structure of health care. Site-neutral payment policies, for example, would address differences in payments for similar services delivered in different settings. Antitrust enforcement and price transparency could draw attention to hospital systems, insurers and drugmakers, but the analysts’ comments describe options rather than settled plans.

Products Worth Considering

Logitech MX Keys Combo for Business Keyboard and Mouse - Graphite

Logitech MX Keys Combo for Business Keyboard and Mouse – Graphite

Bose SoundLink Flex Bluetooth Speaker (2nd Gen) – Portable Outdoor Speaker with Hi‑Fi Audio, Waterproof and Dustproof, USB‑C, Up to 12 Hours
LG UltraGear 32GS60QC-B 32-inch Curved QHD Gaming Monitor (180Hz, 1ms, 1000R, AMD FreeSync, HDR10)

LG UltraGear 32GS60QC-B 32-inch Curved QHD Gaming Monitor (180Hz, 1ms, 1000R, AMD FreeSync, HDR10)

As an affiliate, we earn on qualifying purchases.

The Policy Choices Ahead

The report followed an election that will put Democrats in control of Congress next year. Mirken pointed to newly elected public health advocates, including Abdul El-Sayed, a physician elected to the Senate, and incoming representatives Richard Pan, a physician from California, and Mitchell Berman, a nurse from Wisconsin. He said their presence could add more public health voices to congressional debate.

Medicaid is another likely point of debate. Edwin Park, a research professor at Georgetown University’s Center for Children and Families, said lawmakers may try to repeal Medicaid and Supplemental Nutrition Assistance Program cuts included in last summer’s reconciliation bill, or delay some of them if repeal fails. He also said Congress must address expiring Medicaid provisions by the end of next year, including funding for Disproportionate Share Hospitals, which serve many low-income patients.

Park said Congress may scrutinize how the Centers for Medicare & Medicaid Services is implementing the reconciliation law, including work-reporting requirements and guidance on Medicaid waiver financing. He argued that some agency actions go beyond what the law requires. He also questioned how information about drug prices and rebates is being disclosed. These are Park’s assessments; the report does not include a CMS response.

“Congress needs to dig in quickly and fix damage done to disease monitoring and tracking, food safety, and health research.”

— Bruce Mirken, communications co-chair at Defend Public Health

What Democrats Can Pass

The report does not identify a formal legislative plan from incoming congressional leaders. It is unclear whether they will pursue an investigation of Kennedy, what any inquiry would examine, or whether impeachment articles would be introduced. Mirken’s call for impeachment is an advocacy position, not an announced congressional action.

It is also unclear which proposals could attract enough votes. The analysts noted that Democrats will not have a veto-proof Senate majority, limiting their ability to enact measures opposed by the president. Miller warned that voter priorities are not specific enough to make a clear reform agenda easy to assemble, and that election-year politics may compete with legislative work.

Details of any proposed changes to surprise billing protections, Medicaid cuts, agency oversight or health cost policies remain unsettled. The report gives no bill text, vote count or timetable for these ideas. Park’s concerns about CMS implementation and transparency are his views; the source does not establish that the agency has violated the law.

Hearings, Deadlines and Legislation

The new Congress is expected to take office next year. If lawmakers adopt the priorities described by the analysts, possible next steps could include oversight hearings, requests for agency records, negotiations over Medicaid provisions and proposals to amend the No Surprises Act. The source does not report that any of those steps has been scheduled.

Congress will also have to address Medicaid provisions that expire next year, including Disproportionate Share Hospital funding, according to Park. Debate over whether to repeal or delay cuts from the reconciliation law could proceed alongside that deadline. The timing and outcome will depend on legislative negotiations and the votes available in both chambers.

For now, the developments to watch are whether Democratic leaders announce an investigation or a health policy agenda, whether they seek changes to the surprise billing law, and how they approach Medicaid funding and CMS oversight. Analysts expect proposals and scrutiny to be more likely than sweeping changes, but legislative plans have yet to be confirmed.

Key Questions

Is Congress opening an investigation into Robert F. Kennedy Jr.?

No investigation was announced in the report. Bruce Mirken urged the next Congress to investigate Kennedy, but that is a recommendation, not a confirmed congressional plan.

What changes to surprise billing are being discussed?

Analyst Tom Miller said there may be limited agreement on adjustments to flaws in the No Surprises Act. The report does not identify specific amendments or a bill.

Could Congress reverse Medicaid cuts?

Edwin Park said lawmakers may try to repeal Medicaid and SNAP cuts in last summer’s reconciliation bill, or seek to delay some cuts if repeal is unsuccessful. No decision has been reported.

Why might the proposals not become law?

The experts cited the lack of a veto-proof Senate majority as a limit on what Democrats can enact. Miller also said competing priorities and election politics could make substantial legislation difficult.

Source: medpagetoday.com

This article is for informational purposes only and is not medical advice. Always consult a qualified healthcare professional about your specific situation.
You May Also Like

How Hearing and Vision Changes Can Overlap in Aging

Keen awareness of how hearing and vision decline overlap in aging reveals crucial insights to help you adapt and stay connected.

The Optimal Settings for Back Pain Exercises

Unlock the secrets to optimal back pain exercises and discover how to tailor your routine for safe, effective relief—your journey to comfort begins here.

Auditory Brainstem Response (ABR) Testing

Auditory Brainstem Response (ABR) testing is a quick, painless procedure that checks…

Moderna And Merck Say Their mRNA Cancer Vaccine Cut Death, Recurrence By 42%

Moderna and Merck report lower two-year recurrence-or-death risk with an mRNA vaccine plus Keytruda in a Phase 3 melanoma trial.